Study: PXR Agonist Prevents Cholesterol Gallstone Disease in Mice

Agonists for pregnane X receptor can prevent cholesterol gallstone disease in mice, according to a study published in Gastroenterology.  

Advertisement

Researchers compared levels of bile salts and cholesterol in PXR-null mice and CGD-sensitive C57L mice after a lithogenic diet. PXR-null mice developed diet-induced CGD, evidenced by decreased biliary bile salts and phospholipids and an increased cholesterol saturation index.

C57L mice given a PXR agonist or St. John’s wort did not develop CGD, shown by increased biliary bile salt and decreased CSI.

Researchers suggest that PXR may be an effective target for CGD prevention.

Read the Gastroenterology abstract on cholesterol gallstone disease.

Read more coverage on gallstones:

Patients With Gallstones More Likely to Die Within 20 Years of Diagnosis

New GI Technology Allows Removal of Gallstones on Outpatient Basis

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.